|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 93 No. 11 (June 1), 1999:
pp. 3736-3749
Engraftment in Nonobese Diabetic Severe Combined Immunodeficient
Mice of Human CD34+ Cord Blood Cells After Ex Vivo
Expansion: Evidence for the Amplification and Self-Renewal of
Repopulating Stem Cells
Wanda Piacibello,
Fiorella Sanavio,
Antonella Severino,
Alessandra Danè,
Loretta Gammaitoni,
Franca Fagioli,
Eliana Perissinotto,
Giuliana Cavalloni,
Orit Kollet,
Tsvee Lapidot, and
Massimo Aglietta
From the Department of Biomedical Sciences and Human Oncology,
University of Torino Medical School, Torino; the Hematology/Oncology
Section, Mauriziano Hospital, Torino; the Pediatric Department; the
Institute for Cancer Research and Treatment (IRCC), Candiolo, Torino,
Italy; and the Department of Immunology, the Weizmann Institute of
Science, Rehovot, Israel.
Understanding the repopulating characteristics of human
hematopoietic stem/progenitor cells is crucial for predicting their performance after transplant into patients receiving high-dose radiochemotherapy. We have previously reported that CD34+
cord blood (CB) cells can be expanded in vitro for several months in
serum containing culture conditions. The use of combinations of
recombinant early acting growth factors and the absence of stroma was
essential in determining this phenomenon. However, the effect of these
manipulations on in vivo repopulating hematopoietic cells is not known.
Recently, a new approach has been developed to establish an in vivo
model for human primitive hematopoietic precursors by transplanting
human hematopoietic cells into sublethally irradiated nonobese diabetic
severe combined immunodeficient (NOD/SCID) mice. We have examined here
the expansion of cells, CD34+ and
CD34+38 subpopulations, colony-forming
cells (CFC), long-term culture initiating cells (LTC-IC) and the
maintenance or the expansion of SCID-repopulating cells (SRC) during
stroma-free suspension cultures of human CD34+ CB cells
for up to 12 weeks. Groups of sublethally irradiated NOD/SCID mice were
injected with either 35,000, 20,000, and 10,000 unmanipulated
CD34+ CB cells, which were cryopreserved at the start of
cultures, or the cryopreserved cells expanded from 35,000, 20,000, or
10,000 CD34+ cells for 4, 8, and 12 weeks in the presence
of a combination of early acting recombinant growth factors (flt 3/flk2
ligand [FL] + megakaryocyte growth and development factor [MGDF] ± stem cell factor [SCF] ± interleukin-6 [IL-6]).
Mice that had been injected with  20,000 fresh or cryopreserved
uncultured CD34+ cells did not show any sign or showed
little engraftment in a limited number of animals. Conversely, cells
that had been generated by the same number of initial
CD34+ CB cells in 4 to 10 weeks of expansion cultures
engrafted the vast majority of NOD/SCID mice. The level of engraftment,
well above that usually observed when the same numbers of uncultured cells were injected in the same recipients (even in the presence of
irradiated CD34 cells) suggested that primitive
hematopoietic cells were maintained for up to 10 weeks of cultures. In
addition, dilution experiments suggest that SRC are expanded more than
70-fold after 9 to 10 weeks of expansion. These results support and
extend our previous findings that CD34+ CB stem cells
(identified as LTC-IC) could indeed be grown and expanded in vitro for
an extremely long period of time. Such information may be essential to
design efficient stem cell expansion procedures for clinical use.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Tesio, L. Gammaitoni, M. Gunetti, V. Leuci, Y. Pignochino, N. Jordaney, S. Capellero, C. Cammarata, L. Caione, G. Migliaretti, et al.
Sustained Long-Term Engraftment and Transgene Expression of Peripheral Blood CD34+ Cells Transduced with Third-Generation Lentiviral Vectors
Stem Cells,
June 1, 2008;
26(6):
1620 - 1627.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Araki, K. Yoshinaga, P. Boccuni, Y. Zhao, R. Hoffman, and N. Mahmud
Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential
Blood,
April 15, 2007;
109(8):
3570 - 3578.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Vanheusden, S. Van Coppernolle, M. De Smedt, J. Plum, and B. Vandekerckhove
In Vitro Expanded Cells Contributing to Rapid Severe Combined Immunodeficient Repopulation Activity Are CD34+38-33+90+45RA-
Stem Cells,
January 1, 2007;
25(1):
107 - 114.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Kobari, M. C. Giarratana, J. C. Gluckman, L. Douay, and M. Rosenzwajg
Ex Vivo Expansion Does Not Alter the Capacity of Umbilical Cord Blood CD34+ Cells to Generate Functional T Lymphocytes and Dendritic Cells
Stem Cells,
September 1, 2006;
24(9):
2150 - 2157.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. T. J. Wierenga, H. Schepers, M. A. S. Moore, E. Vellenga, and J. J. Schuringa
STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBP{alpha}
Blood,
June 1, 2006;
107(11):
4326 - 4333.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Gammaitoni, S. Lucchi, S. Bruno, M. Tesio, M. Gunetti, Y. Pignochino, G. Migliardi, L. Lazzari, M. Aglietta, P. Rebulla, et al.
Serial Transplantations in Nonobese Diabetic/Severe Combined Immunodeficiency Mice of Transduced Human CD34+ Cord Blood Cells: Efficient Oncoretroviral Gene Transfer and Ex Vivo Expansion Under Serum-Free Conditions
Stem Cells,
May 1, 2006;
24(5):
1201 - 1212.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Ioannidis, L. G. Mahaira, S. A. Perez, A. D. Gritzapis, P. A. Sotiropoulou, G. J. Kavalakis, A. I. Antsaklis, C. N. Baxevanis, and M. Papamichail
CRD-BP/IMP1 Expression Characterizes Cord Blood CD34+ Stem Cells and Affects c-myc and IGF-II Expression in MCF-7 Cancer Cells
J. Biol. Chem.,
May 20, 2005;
280(20):
20086 - 20093.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. K. Ballen
New trends in umbilical cord blood transplantation
Blood,
May 15, 2005;
105(10):
3786 - 3792.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Byk, J. Kahn, O. Kollet, I. Petit, S. Samira, S. Shivtiel, H. Ben-Hur, A. Peled, W. Piacibello, and T. Lapidot
Cycling G1 CD34+/CD38+ Cells Potentiate the Motility and Engraftment of Quiescent G0 CD34+/CD38-/low Severe Combined Immunodeficiency Repopulating Cells
Stem Cells,
April 1, 2005;
23(4):
561 - 574.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. De Felice, C. Tatarelli, M. G. Mascolo, C. Gregorj, F. Agostini, R. Fiorini, V. Gelmetti, S. Pascale, F. Padula, M. T. Petrucci, et al.
Histone Deacetylase Inhibitor Valproic Acid Enhances the Cytokine-Induced Expansion of Human Hematopoietic Stem Cells
Cancer Res.,
February 15, 2005;
65(4):
1505 - 1513.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Yang, I. Dybedal, D. Bryder, L. Nilsson, E. Sitnicka, Y. Sasaki, and S. E. W. Jacobsen
IFN-{gamma} Negatively Modulates Self-Renewal of Repopulating Human Hemopoietic Stem Cells
J. Immunol.,
January 15, 2005;
174(2):
752 - 757.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. Chute, G. G. Muramoto, J. Fung, and C. Oxford
Soluble factors elaborated by human brain endothelial cells induce the concomitant expansion of purified human BM CD34+CD38- cells and SCID-repopulating cells
Blood,
January 15, 2005;
105(2):
576 - 583.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Tao, M. Wang, E. D. Voss, R. R. Cocklin, J. A. Smith, S. H. Cooper, and H. E. Broxmeyer
Comparative Proteomic Analysis of Human CD34+ Stem/Progenitor Cells and Mature CD15+ Myeloid Cells
Stem Cells,
November 1, 2004;
22(6):
1003 - 1014.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Schuringa, K. Y. Chung, G. Morrone, and M. A.S. Moore
Constitutive Activation of STAT5A Promotes Human Hematopoietic Stem Cell Self-Renewal and Erythroid Differentiation
J. Exp. Med.,
September 7, 2004;
200(5):
623 - 635.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. J. Summers, C. M. Heyworth, E. A. de Wynter, C. A. Hart, J. Chang, and N. G. Testa
AC133+ G0 Cells from Cord Blood Show a High Incidence of Long-Term Culture-Initiating Cells and a Capacity for More Than 100 Million-Fold Amplification of Colony-Forming Cells In Vitro
Stem Cells,
September 1, 2004;
22(5):
704 - 715.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Ivanovic, F. Hermitte, P. B. de la Grange, B. Dazey, F. Belloc, F. Lacombe, G. Vezon, and V. Praloran
Simultaneous Maintenance of Human Cord Blood SCID-Repopulating Cells and Expansion of Committed Progenitors at Low O2 Concentration (3%)
Stem Cells,
September 1, 2004;
22(5):
716 - 724.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Gammaitoni, K. C. Weisel, M. Gunetti, K.-D. Wu, S. Bruno, S. Pinelli, A. Bonati, M. Aglietta, M. A. S. Moore, and W. Piacibello
Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication
Blood,
June 15, 2004;
103(12):
4440 - 4448.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Bruno, M. Gunetti, L. Gammaitoni, E. Perissinotto, L. Caione, F. Sanavio, F. Fagioli, M. Aglietta, and W. Piacibello
Fast But Durable Megakaryocyte Repopulation and Platelet Production in NOD/SCID Mice Transplanted with Ex-Vivo Expanded Human Cord Blood CD34+ Cells
Stem Cells,
March 1, 2004;
22(2):
135 - 143.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. Chute, G. Muramoto, J. Fung, and C. Oxford
Quantitative Analysis Demonstrates Expansion of SCID-Repopulating Cells and Increased Engraftment Capacity in Human Cord Blood Following Ex Vivo Culture with Human Brain Endothelial Cells
Stem Cells,
March 1, 2004;
22(2):
202 - 215.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Rollini, S. Kaiser, E. Faes-van't Hull, U. Kapp, and S. Leyvraz
Long-term expansion of transplantable human fetal liver hematopoietic stem cells
Blood,
February 1, 2004;
103(3):
1166 - 1170.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Mazurier, O. I. Gan, J. L. McKenzie, M. Doedens, and J. E. Dick
Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment
Blood,
January 15, 2004;
103(2):
545 - 552.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Leone, E. Perissinotto, G. Cavalloni, V. Fonsato, S. Bruno, N. Surrenti, D. Hong, A. Capaldi, M. Geuna, W. Piacibello, et al.
Expression of the c-ErbB-2/HER2 proto-oncogene in normal hematopoietic cells
J. Leukoc. Biol.,
October 1, 2003;
74(4):
593 - 601.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Jaroscak, K. Goltry, A. Smith, B. Waters-Pick, P. L. Martin, T. A. Driscoll, R. Howrey, N. Chao, J. Douville, S. Burhop, et al.
Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System
Blood,
June 15, 2003;
101(12):
5061 - 5067.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. E. Broxmeyer, E. F. Srour, G. Hangoc, S. Cooper, S. A. Anderson, and D. M. Bodine
High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years
PNAS,
January 21, 2003;
100(2):
645 - 650.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Denning-Kendall, S. Singha, B. Bradley, and J. Hows
Cytokine Expansion Culture of Cord Blood CD34+ Cells Induces Marked and Sustained Changes in Adhesion Receptor and CXCR4 Expressions
Stem Cells,
January 1, 2003;
21(1):
61 - 70.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. E. Richard and C. A. Blau
Small-Molecule-Directed Mpl Signaling Can Complement Growth Factors to Selectively Expand Genetically Modified Cord Blood Cells
Stem Cells,
January 1, 2003;
21(1):
71 - 78.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Piacibello, S. Bruno, F. Sanavio, S. Droetto, M. Gunetti, L. Ailles, F. S. de Sio, A. Viale, L. Gammaitoni, A. Lombardo, et al.
Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice
Blood,
December 15, 2002;
100(13):
4391 - 4400.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. Chute, A. A. Saini, D. J. Chute, M. R. Wells, W. B. Clark, D. M. Harlan, J. Park, M. K. Stull, C. Civin, and T. A. Davis
Ex vivo culture with human brain endothelial cells increases the SCID-repopulating capacity of adult human bone marrow
Blood,
December 15, 2002;
100(13):
4433 - 4439.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Challier, L. Cocault, R. Berthier, N. Binart, I. Dusanter-Fourt, G. Uzan, and M. Souyri
The cytoplasmic domain of Mpl receptor transduces exclusive signals in embryonic and fetal hematopoietic cells
Blood,
August 28, 2002;
100(6):
2063 - 2070.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. C. Josephson, G. Vassilopoulos, G. D. Trobridge, G. V. Priestley, B. L. Wood, T. Papayannopoulou, and D. W. Russell
Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors
PNAS,
June 11, 2002;
99(12):
8295 - 8300.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Glimm, P. Tang, I. Clark-Lewis, C. von Kalle, and C. Eaves
Ex vivo treatment of proliferating human cord blood stem cells with stroma-derived factor-1 enhances their ability to engraft NOD/SCID mice
Blood,
May 1, 2002;
99(9):
3454 - 3457.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Grande, M. Montanari, E. Tagliafico, R. Manfredini, T. Z. Marani, M. Siena, E. Tenedini, A. Gallinelli, and S. Ferrari
Physiological levels of 1{alpha}, 25 dihydroxyvitamin D3 induce the monocytic commitment of CD34+ hematopoietic progenitors
J. Leukoc. Biol.,
April 1, 2002;
71(4):
641 - 651.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Dravid and S.G.A. Rao
Ex Vivo Expansion of Stem Cells from Umbilical Cord Blood: Expression of Cell Adhesion Molecules
Stem Cells,
March 1, 2002;
20(2):
183 - 189.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-H. Kie, W.-I. Yang, M.-K. Lee, T.-J. Kwon, Y.-H. Min, H.-O. Kim, H.-S. Ahn, S.-A. Im, H.-L. Kim, H.-Y. Park, et al.
Decrease in Apoptosis and Increase in Polyploidization of Megakaryocytes by Stem Cell Factor During Ex Vivo Expansion of Human Cord Blood CD34+ Cells Using Thrombopoietin
Stem Cells,
January 1, 2002;
20(1):
73 - 79.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. J. Summers, C. M. Heyworth, E. A. de Wynter, J. Chang, and N. G. Testa
Cord Blood G0 CD34+ Cells Have A Thousand-Fold Higher Capacity For Generating Progenitors In Vitro Than G1 CD34+ Cells
Stem Cells,
November 1, 2001;
19(6):
505 - 513.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
C. Tonnelle, F. Bardin, C. Maroc, A.-M. Imbert, F. Campa, A. Dalloul, C. Schmitt, and C. Chabannon
Forced expression of the Ikaros 6 isoform in human placental blood CD34+ cells impairs their ability to differentiate toward the B-lymphoid lineage
Blood,
November 1, 2001;
98(9):
2673 - 2680.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Dybedal, D. Bryder, A. Fossum, L. S. Rusten, and S. E. W. Jacobsen
Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells
Blood,
September 15, 2001;
98(6):
1782 - 1791.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. D. Lewis, G. Almeida-Porada, J. Du, I. R. Lemischka, K. A. Moore, E. D. Zanjani, and C. M. Verfaillie
Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system
Blood,
June 1, 2001;
97(11):
3441 - 3449.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
